Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← Analysis & Perspectives
MillimanFebruary 9, 2026

How Risk Adjustment Systems Drive Medicaid Plan Revenue and Formulary Decisions

Life sciences companies seeking to understand Medicaid managed care purchasing behavior need to grasp how risk adjustment models translate member acuity into plan payments and profitability. The piece explains that Medicaid capitation rates are risk-adjusted based on enrollee health conditions and demographics, directly affecting plan revenue and financial performance. Because risk scores influence plan margins, they also shape formulary design and coverage decisions—meaning pharmaceutical manufacturers must account for how their products affect plan risk profiles and reimbursement.

Managed Care · Pharmacy · Finance

Read the full analysis at Milliman →

This is outside commentary from Milliman, not part of Medicaid Monitor's independently scored news coverage.

Share this

More from Milliman

← Analysis & Perspectives

Get the daily briefing.